Latest Articles

Publication Date
Superficial heat therapy in women's health.

Female-specific pain conditions such as dysmenorrhoea, endometriosis, and pain associated with pregnancy, childbirth, and menopause are highly prevalent and frequently impair quality of life. Superficial heat therapy (SHT) has long …

Published: June 26, 2026, midnight
BBC star Naga Munchetty fainted before going on air and suffers so much pain she throws up - The Mirror

BBC star Naga Munchetty fainted before going on air and suffers so much pain she throws up The Mirror

Published: June 25, 2026, 7:03 p.m.
Correction: Endometrioid cancer associated with endometriosis: from the seed and soil theory to clinical practice.

[This corrects the article DOI: 10.3389/fonc.2022.859510.].

Published: June 25, 2026, midnight
Comparative study of quality of life between endometriosis patients receiving GnRH agonist and dienogest therapy: A cross-sectional study using Endometriosis Health Profile-30 (EHP-30).

Endometriosis is a chronic gynecological disease that substantially impairs quality of life. Gonadotropin-releasing hormone (GnRH) agonists and dienogest are commonly used hormonal therapies for endometriosis; however, direct comparisons of their …

Published: June 25, 2026, midnight
Eli Lilly dives into hair loss treatments with investment in AI startup Absci - statnews.com

Eli Lilly dives into hair loss treatments with investment in AI startup Absci statnews.com

Published: June 24, 2026, 8:05 p.m.
ABSI Stock Eyes Best Day Ever After Positive Hair Loss Drug Data, $100M Lilly-Backed Raise - TradingView

ABSI Stock Eyes Best Day Ever After Positive Hair Loss Drug Data, $100M Lilly-Backed Raise TradingView

Published: June 24, 2026, 7:55 p.m.
Hair Relaxer Lawsuit Settlement | June 2026 Litigation Update - Lawsuit Information Center

Hair Relaxer Lawsuit Settlement | June 2026 Litigation Update Lawsuit Information Center

Published: June 24, 2026, 5:50 p.m.
Absci Raises $100 Million In Equity To Fund AI-Designed Hair Loss And Endometriosis Program - Benzinga

Absci Raises $100 Million In Equity To Fund AI-Designed Hair Loss And Endometriosis Program Benzinga

Published: June 24, 2026, 1:09 p.m.
Absci stock surges 24% on positive Phase 1 hair loss drug data - Investing.com South Africa

Absci stock surges 24% on positive Phase 1 hair loss drug data Investing.com South Africa

Published: June 24, 2026, 11:14 a.m.
Absci stock surges 24% on positive Phase 1 hair loss drug data By Investing.com - Investing.com India

Absci stock surges 24% on positive Phase 1 hair loss drug data By Investing.com Investing.com India

Published: June 24, 2026, 11:13 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!